3 ms·
Oh, well, sure. But the COVID vaccines even at peak production will likely only be using a single digit percentage of the endotoxin tests done in the US in a t
by mlyle 6y ago
Oh, well, sure. But the COVID vaccines even at peak production will likely only be using a single digit percentage of the endotoxin tests done in the US in a typical year. In no way can this be considered limiting.
About 60k doses/lot, figure 30 endotoxin tests per lot, that's 1 test per 2k doses =~ 300k endotoxin tests to vaccinate the US.
- maxerickson 6y agoI guess I can't say I've read them closely, but I don't recall any of the recent articles about the crabs having figures like that (which it is good that it isn't a problem, I'm referring to the articles not getting to the important bit about it not being an issue).
- mlyle 6y agohttps://www.baltimoresun.com/coronavirus/bs-md-coronavirus-horseshoe-crab-blood-vaccine-20201231-gijaccmxf5dabh4l36nzve6jre-story.html https://www.baltimoresun.com/coronavirus/bs-md-coronavirus-h... "For now, the industry says it has plenty of horseshoe crab blood to screen coronavirus vaccines. Pharmaceutical companies test a sample from a batch of vaccines, not every dose. And that sample size, say three vials, doesn’t change whether the batch contains 100,000 doses or 1 million, says Allen Burgenson of Lonza. In fact, Burgenson says, the industry produces enough tests in one day to screen 5 billion doses of coronavirus vaccine." (I think this is unduly optimistic, because mfrs are likely to screen at multiple steps during production, since the latency of batches is ~100 days, and because lot sizes aren't so large yet. So divide 5 billion by a small integer).